{"title":"Perioperative Management of Oral Anticoagulation: A Real-World Observational Study","authors":"P. Lo sapio","doi":"10.61148/2836-2837/ijccci/005","DOIUrl":null,"url":null,"abstract":"Aims:Using a retrospective study, we evaluated: the risk of thromboembolism and bleeding following the perioperative management of oral anticoagulants (OACs) and the adherence to the guidelines by the clinicians involved. Methods:Six hundred procedures, 120 for each OAC were collected from a Central Tuscany Surgery Department database. The endpoints were:the 30-days rate of arterial, venous thrombotic events and bleedings, classified by ISTH, and their association with adherence to EHRA guidelines. Results: Three hundreds and seventy one procedures(61%) were at high risk of bleeding. Until 30 days of follow-up, thrombotic events occurred in 4 patients, 7% total bleedings;12.8% of bleedings occurred in inappropriate heparin bridging and 5.7% in patients without bridging (p <.016). Four hundred and forty two (73.7%) procedures were performed in complete adherence to guidelines. At the multivariate analysis inappropriate bridging (HR=2.3;95% CI 1.1-4.7; p=.021) and urologic interventions (HR=2.3;95% CI 1.2-4.4;p=.01) were independent risk factors for bleeding events. Conclusions: Bleedings were significantly correlated with inappropriate heparin bridging even if occurred also in correct management of OACs, being related to the major surgery itself.","PeriodicalId":153375,"journal":{"name":"International Journal of Clinical Cardiology and Cardiovascular Interventions","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Cardiology and Cardiovascular Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.61148/2836-2837/ijccci/005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Aims:Using a retrospective study, we evaluated: the risk of thromboembolism and bleeding following the perioperative management of oral anticoagulants (OACs) and the adherence to the guidelines by the clinicians involved. Methods:Six hundred procedures, 120 for each OAC were collected from a Central Tuscany Surgery Department database. The endpoints were:the 30-days rate of arterial, venous thrombotic events and bleedings, classified by ISTH, and their association with adherence to EHRA guidelines. Results: Three hundreds and seventy one procedures(61%) were at high risk of bleeding. Until 30 days of follow-up, thrombotic events occurred in 4 patients, 7% total bleedings;12.8% of bleedings occurred in inappropriate heparin bridging and 5.7% in patients without bridging (p <.016). Four hundred and forty two (73.7%) procedures were performed in complete adherence to guidelines. At the multivariate analysis inappropriate bridging (HR=2.3;95% CI 1.1-4.7; p=.021) and urologic interventions (HR=2.3;95% CI 1.2-4.4;p=.01) were independent risk factors for bleeding events. Conclusions: Bleedings were significantly correlated with inappropriate heparin bridging even if occurred also in correct management of OACs, being related to the major surgery itself.
目的:通过一项回顾性研究,我们评估了围手术期口服抗凝剂(OACs)治疗后血栓栓塞和出血的风险,以及临床医生对指南的遵守情况。方法:从中央托斯卡纳外科数据库中收集600例手术,每种OAC 120例。终点是:30天内动脉、静脉血栓形成事件和出血发生率,按ISTH分类,以及它们与遵守EHRA指南的关系。结果:371例手术存在高危出血,占61%。截至随访30天,4例患者发生血栓形成事件,总出血7%;12.8%的出血发生在肝素桥接不当的患者中,5.7%发生在未桥接的患者中(p < 0.016)。442例(73.7%)手术完全按照指南进行。在多变量分析中,不适当的桥接(HR=2.3;95% CI 1.1-4.7;p= 0.021)和泌尿系统干预(HR=2.3;95% CI 1.2-4.4;p= 0.01)是出血事件的独立危险因素。结论:出血与肝素桥接不当相关,即使在正确处理OACs时也会发生,与大手术本身有关。